The clinical-trials bottleneck.
D001943:Breast Neoplasms; D003362:Cost-Benefit Analysis; D003657:Decision Making; D015507:Drugs, Investigational; D017041:Ethics Committees; D028744:Ethics Committees, Research; D005380:Financing, Government; D007722:Health Knowledge, Attitudes, Practice; D006279:Health Maintenance Organizations; D006805:Human Experimentation; D006801:Humans; D007349:Insurance, Health, Reimbursement; D009369:Neoplasms; D033281:Nontherapeutic Human Experimentation; D010344:Patient Advocacy; D018579:Patient Selection; D010361:Patients; D010820:Physicians; D011336:Probability; D011827:Radiation; D011897:Random Allocation; D012106:Research; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation; D035501:Uncertainty; D014481:United States
Biomedical and Behavioral Research; National Cancer Institute; Popular Approach/Source